Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial.
about
Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Pharmacogenetic study of the i ...... quent phase II clinical trial.
@en
Pharmacogenetic study of the i ...... quent phase II clinical trial.
@nl
type
label
Pharmacogenetic study of the i ...... quent phase II clinical trial.
@en
Pharmacogenetic study of the i ...... quent phase II clinical trial.
@nl
prefLabel
Pharmacogenetic study of the i ...... quent phase II clinical trial.
@en
Pharmacogenetic study of the i ...... quent phase II clinical trial.
@nl
P2093
P2860
P50
P921
P1476
Pharmacogenetic study of the i ...... quent phase II clinical trial.
@en
P2093
Agneta Swedin
Astrid Gruber
Birgitta Lauri
Cecilie Blimark
Conny Carlsson
Henrik Gréen
Johan Lund
Karin Forsberg
Kourosh Lotfi
Lucia Ahlberg
P2860
P2888
P304
P356
10.1007/S00280-017-3481-8
P577
2017-11-25T00:00:00Z